Acumen Pharmaceuticals, Inc. (ABOS) vs Humacyte, Inc. (HUMA)
- Acumen Pharmaceuticals, Inc. ABOS 1.69 +1.20%
- Humacyte, Inc. HUMA 0.43 −2.27%
Acumen Pharmaceuticals, Inc. and Humacyte, Inc. are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and Humacyte, Inc. are of similar size ($122.1M and $120.8M). Acumen Pharmaceuticals, Inc. has the higher net margin (0.00% vs −4,448.9%) and the higher return on invested capital (0.00% vs −433.7%). Across the 16 metrics below, Acumen Pharmaceuticals, Inc. leads on 11 and Humacyte, Inc. on 5.
Valuation
Profitability
| Metric | ABOS | HUMA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | (494.58%) | 65.16% |
| Operating margin | 0.00% | (5,240.78%) | 0.00% |
| Net margin | 0.00% | (4,448.89%) | 0.00% |
| Free cash flow margin | 0.00% | (4,599.72%) | 0.00% |
| Return on equity | (120.50%) | (534.42%) | (56.36%) |
| Return on assets | (72.97%) | (68.16%) | (48.04%) |
| Return on invested capital | 0.00% | (433.66%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack